| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ardelyx, Inc. (ARDX) has 9 insiders with recent SEC Form 4 filings, including 2 buys and 8 sells. ARDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 3.30M | $20.41M | - | |
| CEO | 1.74M | $10.76M | -41,666 | |
| Other | 409.9K | $2.53M | - | |
| CFO | 409.1K | $2.53M | - | |
| Other | 339.5K | $2.10M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2015 | Raab Michael56 | President &CEO | Sell | 1,104 | $20.00 | $22,080.00 | -1.4% | |
| Aug 6, 2015 | Jacobs Jeffrey W66 | SVP, Technical Operations | Sale+OE | 2,000 | $19.07 | $38,140.00 | -4.1% | |
| Aug 3, 2015 | Raab Michael56 | President &CEO | Sell | 300 | $20.00 | $6,000.00 | -0.4% | |
| Jul 30, 2015 | Rosenbaum David P.59 | SVP, Drug Development | Sell | 2,011 | $19.27 | $38,755.19 | -2.6% | |
| Jul 28, 2015 | Raab Michael56 | President &CEO | Sell | 2,111 | $20.00 | $42,220.00 | -2.5% | |
| Jul 28, 2015 | Jacobs Jeffrey W66 | Senior VP, Technical Ops | Sale+OE | 2,500 | $20.00 | $50,000.00 | -5.1% | |
| Jul 22, 2015 | Grammer Elizabeth A58 | VP, General Counsel | Sale+OE | 2,500 | $18.00 | $45,000.00 | -100% | |
| Jul 15, 2015 | Grammer Elizabeth A58 | VP, General Counsel | Sale+OE | 10,000 | $17.12 | $171,150.00 | -100% | |
| Jun 10, 2015 | Ringold Gordon | Director | Buy | 10,000 | $15.19 | $151,880.00 | New | |
| Jun 5, 2015 | Barrett M James | 10% Owner | Buy | 1,869,159 | $10.70 | $20,000,001.30 | +33.3% |